A man conducting lab research

A survey to assess antibody responses to COVID-19 vaccines among cancer patients

Test your antibodies and contribute to an important study into COVID-19 vaccines and cancer patients.

What is the project about?

NHS England has launched a national COVID Cancer Antibody Survey to assess antibody responses to the COVID-19 vaccines among cancer patients.


Vaccination is an important strategy to protect society from the effects of COVID-19, but there is emerging evidence that a small number of cancer patients may have lower levels of antibody response than the general population. 


The COVID Cancer Antibody Survey is one of the first surveys of its kind that will help us understand what protection people with cancer develop following COVID-19 infection.

What are the criteria for taking part?

The survey is open to people aged 18 or over, living in England, with a diagnosis of cancer within the last year OR anyone who is on tablet/ intravenous treatments for their cancer. It is also open to anyone who is receiving radiotherapy.
Participants will be sent a finger-prick blood test that looks for antibodies against COVID-19 in the blood. It will be sent in the post and comes with everything needed to complete and return the test.

Become a Breast Cancer Voice

Would you like to hear about more opportunities like this one, as well as lots of other exciting ways to make your voice heard? Breast Cancer Voices are people whose lives have been changed by breast cancer. They use their diverse experiences to shape our work.

Find out how you can become a Voice today